Position in RXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
19 quarters on record
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Derivatives in RXRX
reported options exposure · as of Jun 30, 2026CallValue
$2,140,344
CallShares
583,200
PutValue
$713,081
PutShares
194,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in RXRX
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,140,344 | 583,200 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $713,081 | 194,300 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $613,079 | 199,700 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $2,094,047 | 682,100 | Call | Defined | 2026-05-12 | |
| 2025-12-31 | $2,570,156 | 628,400 | Put | Defined | 2026-02-12 | |
| 2025-12-31 | $2,868,317 | 701,300 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $511,556 | 125,075 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $669,048 | 137,100 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $387,960 | 79,500 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $3,521,183 | 721,554 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,751,772 | 346,200 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $692,714 | 136,900 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $1,722,302 | 325,577 | Call | Defined | 2025-05-19 | |
| 2025-03-31 | $1,536,745 | 290,500 | Put | Defined | 2025-05-19 | |
| 2024-12-31 | $2,104,388 | 311,300 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $1,460,680 | 216,077 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $2,385,299 | 352,855 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $667,567 | 101,300 | Put | Defined | 2024-11-15 | |
| 2024-09-30 | $681,406 | 103,400 | Call | Defined | 2024-11-15 | |
| 2024-09-30 | $1,568,636 | 238,033 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $4,314,247 | 575,233 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $2,113,140 | 211,950 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $3,378,636 | 342,661 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $272,064 | 35,564 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $788,099 | 105,502 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $633,456 | 94,971 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $208,885 | 27,093 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $367,334 | 34,524 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $194,082 | 23,843 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $100,002 | 13,967 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $309,453 | 18,065 | Shares | Defined | 2022-02-15 | |
| No filing history on record for this holder in this stock. | ||||||